InsiderTrades

Form 4 for LH Labcorp

Accepted 2021-11-09 00:00:00 ET · period of report 2021-11-05 · accession 0001127602-21-028660 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-11-09 2021-11-05 LH Schroeder Mark S EVP, Pres-Diagnostics Lab F - Tax $274.84 -899 6,240 -13% -$247.1K
D 2021-11-09 2021-11-05 LH Schroeder Mark S EVP, Pres-Diagnostics Lab M - OptEx — +2,010 7,140 +39% —
D 2021-11-09 2021-11-05 LH Schroeder Mark S EVP, Pres-Diagnostics Lab M - OptEx $0.00 -2,010 4,744 -30% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-11-05 F D 899 $274.84 6,240.50 D — — (F2) Amount includes 123.1200 shares acquired on June 30, 2021 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.
2 Common Common Stock 2021-11-05 M A 2,010 — 7,139.50 D — — (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. (F2) Amount includes 123.1200 shares acquired on June 30, 2021 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.
3 Derivative Restricted Stock Unit 2021-11-05 M D 2,010 $0.00 4,744 D — · — to — 2,010 Common Stock (F5) This number reflects the aggregate number of Restricted Stock Units held by the reporting person. (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. (F4) The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on November 5, 2020.